Kymera Therapeutics, Inc.
NASDAQ:KYMR
49.03 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||
| Net Income
| -42.062 | -48.557 | -14.368 | -52.867 | -38.799 | -40.928 | -34.865 | -43.002 | -40.257 | -36.684 | -33.9 | -28.582 | -24.66 | -13.075 | -12.685 | -7.987 | -13.989 | -10.932 | -11.513 | -11.42 |
| Depreciation & Amortization
| 1.9 | 1.461 | 0.891 | 0.895 | 0.9 | 0.879 | 0.818 | 0.767 | 0.705 | 0.687 | 0.689 | 0.671 | 0.552 | 0.485 | 0.497 | 0.49 | 0.389 | 0.387 | 0.361 | 0.158 |
| Deferred Income Tax
| 0 | 0 | -17.823 | 9.154 | 8.669 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 14.341 | 11.968 | 10.898 | 11.655 | 11.18 | 9.385 | 8.909 | 9.076 | 9.622 | 7.873 | 8.678 | 7.396 | 5.726 | 3.172 | 1.827 | 2.328 | 0.664 | 0.371 | 0.297 | 0.234 |
| Change In Working Capital
| -13.132 | -6.316 | 11.893 | 9.887 | -7.12 | -11.978 | -13.493 | -1.052 | -9.732 | -13.346 | -15.455 | -18.423 | -13.361 | -14.684 | -11.278 | 136.726 | 1.413 | -1.994 | -0.057 | -1.556 |
| Accounts Receivables
| 0.327 | 15 | -14.985 | 0.344 | -0.802 | -0.783 | 0.346 | -0.513 | -1.106 | 0 | 0.577 | 0 | 0 | 0 | -0.577 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 14.985 | -0.344 | 0.802 | 0.783 | -0.346 | 0.513 | 1.106 | 0 | 1.602 | 0 | 0 | 0 | 0.585 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0.031 | 0.075 | 1.531 | 1.02 | -2.73 | 2.217 | -2.068 | 4.168 | -0.41 | -1.437 | -1.028 | -2.923 | -0.145 | 4.15 | 0.467 | 0.895 | -0.211 | -0.161 | 1.407 | -1.761 |
| Other Working Capital
| -13.49 | -7.979 | 10.362 | 8.867 | -4.39 | -14.195 | -11.425 | -5.22 | -9.322 | -11.909 | -16.606 | -15.5 | -13.216 | -18.834 | -11.753 | 135.831 | 1.624 | -1.833 | -1.464 | 0.205 |
| Other Non Cash Items
| 13.8 | 15.282 | -1.269 | -10.371 | -10.086 | -1.326 | -0.905 | -0.058 | 0.677 | 1.175 | 1.636 | 1.678 | 1.232 | 1.279 | 1.571 | 0.11 | 0.111 | 0.111 | 0.111 | 0.11 |
| Operating Cash Flow
| -42.936 | -39.591 | 8.045 | -31.647 | -35.256 | -43.968 | -39.536 | -34.269 | -38.985 | -40.295 | -38.352 | -37.26 | -30.511 | -22.823 | -20.068 | 131.667 | -11.412 | -12.057 | -10.801 | -12.474 |
| Investing Activities: | ||||||||||||||||||||
| Investments In Property Plant And Equipment
| -4.689 | -7.402 | -11.625 | -8.078 | -10.768 | -4.009 | -0.373 | -1.246 | -0.735 | -0.482 | -0.501 | -0.306 | -0.626 | -0.164 | -1.437 | -2.409 | -3.855 | -1.395 | -0.199 | -0.211 |
| Acquisitions Net
| 0 | 0 | -30.577 | -68.589 | -46.607 | -1.326 | 0.889 | 36.235 | -82.538 | 1.175 | 5.807 | 0 | 0 | 1.279 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -104.156 | -422.704 | -45.504 | -29.17 | -52.642 | -61.835 | -147.236 | -153.909 | -64.709 | -80.118 | -164.398 | -245.842 | -30.151 | -16.013 | -68.443 | -350.412 | -74.519 | -36.008 | 62.158 | -78.112 |
| Sales Maturities Of Investments
| 124.487 | 99.499 | 76.081 | 97.759 | 99.249 | 90.428 | 97.943 | 117.674 | 147.247 | 106.463 | 96.88 | 109.286 | 91.5 | 60.5 | 65.89 | 18.5 | 31.5 | 0 | 0 | 0 |
| Other Investing Activites
| 20.331 | 3.072 | 30.577 | 68.589 | 46.607 | 1.326 | -0.889 | -36.235 | 82.538 | -1.175 | -5.807 | 0 | 0 | -1.279 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 15.642 | -330.607 | 18.952 | 60.511 | 35.839 | 24.584 | -49.666 | -37.481 | 81.803 | 25.863 | -68.019 | -136.862 | 60.723 | 44.323 | -3.99 | -334.321 | -46.874 | -37.403 | 61.959 | -78.323 |
| Financing Activities: | ||||||||||||||||||||
| Debt Repayment
| -0.352 | -0.29 | -0.925 | -0.34 | -0.334 | -0.327 | -0.305 | -0.292 | -0.269 | -0.264 | -0.156 | -0.352 | -0.186 | -0.155 | -0.152 | -0.109 | -0.151 | -0.142 | -0.118 | -0.085 |
| Common Stock Issued
| 1.764 | 350.113 | 1.009 | 0.134 | 1.639 | 1.486 | 149.825 | 150.789 | 0.633 | 0 | -0.029 | 0 | 0 | 0 | 0.398 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.764 | 52.673 | 1.85 | -0.206 | 1.305 | 1.159 | -147.567 | 150.497 | 0.633 | 0.449 | 2.239 | 246.391 | 1.778 | 0.75 | 0.024 | 196.384 | -0.252 | 93.262 | 21.211 | 0.044 |
| Financing Cash Flow
| 1.412 | 353.756 | 1.934 | -0.206 | 1.305 | 1.159 | 1.953 | 150.497 | 0.364 | 0.185 | 2.054 | 246.039 | 1.592 | 0.595 | 0.27 | 196.275 | -0.403 | 93.12 | 21.093 | -0.041 |
| Other Information: | ||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0.001 | -18.287 | 8.198 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -25.898 | -16.456 | 28.932 | 28.658 | 1.888 | -18.225 | -87.249 | 78.747 | 43.182 | -14.247 | -104.317 | 71.917 | 31.804 | 22.095 | -23.788 | -6.379 | -58.689 | 43.66 | 72.251 | -90.838 |
| Cash At End Of Period
| 67.612 | 93.51 | 115.777 | 86.845 | 58.187 | 56.299 | 74.525 | 161.774 | 83.027 | 39.845 | 54.092 | 158.409 | 86.492 | 54.688 | 32.593 | 56.381 | 62.76 | 121.449 | 77.789 | 5.538 |